Recombinant canstatin inhibits VEGF‐A‐induced lymphangiogenesis and metastasis in an oral squamous cell carcinoma SCC‐VII animal model

We describe the inhibitory effects of recombinant canstatin on tumor growth and lymphangiogenesis induced by an oral squamous cell carcinoma (SCC) using an orthotropic oral SCC animal model. Recombinant canstatin treatment decreased final tumor volumes and weights, as well as densities of blood and...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang‐Bo, Jeon, Park, Jong‐Hwa, Bae, Mun Gyeong, Chung, In Sik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Cancer Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083751/
https://www.ncbi.nlm.nih.gov/pubmed/27650585
http://dx.doi.org/10.1002/cam4.866

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083751/
https://www.ncbi.nlm.nih.gov/pubmed/27650585
http://dx.doi.org/10.1002/cam4.866

Ejemplares similares